Production of 20 obsolete drugs to be re-initiated

Influenced by a new positive list system, some drug companies are expected to re-produce a total of 20 obsolete medicines, including Daewoong Pharm's Moxicle tablet and ceftazidime 1g, from December 1.

Their movement came as the government plans to exclude some obsolete drugs from the list of all insured medicines, readjust prices of brand-name drugs when their patents expire and re-evaluate...